SUBSCRIBE
SUBSCRIBE

BioSpace Insights

The BioSpace Insights team performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.

Pictured: Silhouettes of people on report cover
Employer Resources
Report: The State of Diversity, Equity, Inclusion and Belonging in Life Sciences
BioSpace’s third report on diversity, equity, inclusion and belonging in life sciences examines dramatic shifts in attitude around diversity initiatives.
May 6, 2024
 · 
1 min read
 · 
BioSpace Insights
Business
A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach
Takeda Oncology US Head of Sales, Annette Montandon, discusses how embodying a patient-first approach is key to the success of colorectal cancer drug FRUZAQLA®.
April 24, 2024
 · 
4 min read
 · 
BioSpace Insights
Money Talk: Salary Trends and Raises
This week, we’re talking money! Following the release of BioSpace’s ⁠2024 Salary Report⁠, we discuss salary trends and how they are impacting the biopharma workforce.
March 21, 2024
 · 
1 min read
 · 
BioSpace Insights
Job Trends
Report: 2024 U.S. Life Sciences Salary Trends
BioSpace’s 2024 Salary Report explores the average salaries and salary trends of life sciences professionals.
March 18, 2024
 · 
1 min read
 · 
BioSpace Insights
Employer Resources
What can biopharma expect from the job market?
BioSpace’s Lori Ellis and Chantal Dresner discuss anticipated job market trends for 2024 including unemployment, anticipated job search activity and hiring trends.
January 25, 2024
 · 
1 min read
 · 
BioSpace Insights
Employer Resources
Report: 2024 Employment Outlook
BioSpace’s Employment Outlook report investigates anticipated job search activity and hiring outlook in 2024 as well as how the current workforce is currently faring
January 19, 2024
 · 
1 min read
 · 
BioSpace Insights
Deals
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics
BioSpace and guests from Halia Therapeutics, Triumvira Immunologics and the Alzheimer’s Drug Discovery Foundation discuss alternative financing strategies to consider for 2024. Listen now.
January 4, 2024
 · 
1 min read
 · 
BioSpace Insights
What VCs look for when investing with MPM Capital, Endeavor Venture Fund and Two Bear Capital
How can startup leaders support long-term sustainable growth and investment? BioSpace’s Lori Ellis speaks with venture capital guests Ansbert Gadicke, Martin Gershon and Mike Goguen for their advice and recommendations on how biopharma startups should approach funding.
December 19, 2023
 · 
1 min read
 · 
BioSpace Insights
Deals
What VCs really think of the market right now with MPM Capital, Endeavor and Two Bear Capital
What needs to happen for funding in biopharma to bounce back? BioSpace’s Lori Ellis discusses the macroeconomic environment and biopharma funding outlook with venture capital guests Ansbert Gadicke, Martin Gershon and Mike Goguen.
December 14, 2023
 · 
1 min read
 · 
BioSpace Insights
Deals
Webinar: Alternative Funding Strategies to Discuss at JPM
BioSpace and guests from Halia Therapeutics, Triumvira Immunologics and the Alzheimer’s Drug Discovery Foundation will discuss alternative financing strategies to consider for 2024. Watch now.
December 12, 2023
 · 
4 min read
 · 
BioSpace Insights
Drug Development
Fast and furious evolution: How to ensure AI is catalyst for positive societal change with Microsoft and IQVIA
In this episode we dive into regulation, real-time management, and AI’s various applications and how it can streamline different processes with guests from Microsoft and IQVIA.
December 12, 2023
 · 
1 min read
 · 
BioSpace Insights
Employer Resources
Integrating AI in life sciences to change employee behavior with Microsoft and IQVIA
In this episode, hear from senior leaders at Microsoft and IQVIA to get their take on how generative AI is impacting productivity, employee engagement and how to mitigate risks.
December 7, 2023
 · 
1 min read
 · 
BioSpace Insights
Drug Development
Artificial Intelligence, Part 3: Improving Communication to Impact Patient Behavior
In this third episode of Denatured’s series on AI in drug discovery, we discuss patient behavior and its influence on clinical trials and AI models with guests from GSK, IQVIA, Exelixis and DataHow.
December 5, 2023
 · 
1 min read
 · 
BioSpace Insights
Drug Development
Artificial Intelligence, Part 2: Human Interaction, Liability, and Patient Safety
Listen to this in-depth discussion on how AI can help identify end-to-end data weaknesses, as well as broader implications regarding the inevitability of human interaction, with guests from GSK, IQVIA, Exelixis and DataHow.
November 30, 2023
 · 
1 min read
 · 
BioSpace Insights
Drug Development
Upstream Bio’s Quest for Effective Best-in-Class Treatments for Allergic Inflammation
Advancements in asthma biologics spell future hope for patients with severe asthma.
November 22, 2023
 · 
6 min read
 · 
BioSpace Insights
Load More